Transcatheter Mitral Valve Repair Safe for Mitral Regurgitation
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, June 5, 2023 -- For patients with degenerative mitral regurgitation (MR), transcatheter edge-to-edge mitral valve repair is safe and has a high rate of success, according to a study published in the May 23/30 issue of the Journal of the American Medical Association.
Raj R. Makkar, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined outcomes among 19,088 U.S. patients (median age, 82 years) with isolated moderate-to-severe or severe degenerative MR who underwent nonemergency transcatheter mitral valve repair with the MitraClip device from 2014 to 2022.
The researchers found that 88.9 percent of the patients achieved MR repair success. The incidence rates of death, stroke, and mitral valve reintervention were 2.7, 1.2, and 0.97 percent, respectively, at 30 days. Compared with an unsuccessful procedure, MR success was associated with significantly lower mortality (14.0 versus 26.7 percent; adjusted hazard ratio, 0.49) and heart failure readmission (8.4 versus 16.9 percent; adjusted hazard ratio, 0.47) at one year. Among patients with MR success, those who had both mild or less residual MR and mean mitral gradients of 5 mm Hg or less had the lowest mortality compared with those with an unsuccessful procedure (11.4 versus 26.7 percent; adjusted hazard ratio, 0.40).
"These strong safety and efficacy outcomes were validated, despite the advanced age and significant comorbidities of these patients," Makkar said in a statement.
Several authors report ties to pharmaceutical and medical device companies, including Abbott, the maker of the MitraClip device.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
FDA Issues Safety Alert for Impella Left-Sided Blood Pump
MONDAY, April 1, 2024 -- The U.S. Food and Drug Administration has issued a warning regarding a heart pump that could perforate a wall in the left ventricle if used...
Use of Transcatheter Aortic Valve Replacement Up in Adults Younger Than 60
TUESDAY, Feb. 13, 2024 -- For patients aged younger than 60 years, transcatheter aortic valve replacement (TAVR) is increasingly used and has overtaken surgical aortic valve...
Digital Air Leak Detection Device Can Help Reduce Chest Tube Duration
WEDNESDAY, Dec. 13, 2023 -- For patients undergoing pulmonary lobectomy, a digital air leak detection device can speed the identification of chest tube air leak cessation...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.